Keywords: Bristol-Myers Squibb, Plaxiv, Sanofi-Aventis, blood thinner

Bristol-Myers Squibb says USPTO to review Plavix patent

Article | 20 August 2009

Print This

US drug major Bristol-Myers Squibb says that its lead drug, Plavix (clopidogrel), the blood thinner co-marketed under an agreement with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in